Authors
Latest:
2014 Biopharma cold-chain forecastGlobal industry will spend $8.36 billion on cold chain logistics this year
Latest:
Integrating patient training into product launchesThe growing market for self-administered injectables calls for better patient-training resources
Latest:
Developing a Center of Excellence (COE) for Financial Planning & AnalysisLife sciences CFOs can address growing cost pressures through decision support centralization
Latest:
Key Account Management: A Win-Win Proposition for Pharmaceutical Companies and Their Major CustomersReorganizing a sales force into key account teams requires more planning and coordination. Access to real-time account information enhances the team effort.
Latest:
Networking for life science logisticsThe Health & Personal Care Logistics Conference brings industry leaders together
Latest:
Supporting pharma’s shift in focus from patient 'outputs’ to ‘outcomes’The rise of the patient voice and increased acceptance of remote engagement are sparking a culture change across the supply chain
Latest:
A scientific approach to site selectionApplying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes
Latest:
Patient access strategy: specialty pharmacy, hub—or both?Do you need to hire a hub service for your Patient Access Strategy or can you get by with a good specialty pharmacy
Latest:
Provisional patent technology filed for cardiovascular disease is for sale or joint ventureCombining sublingual nitroglycerin and aspirin in a tablet or other embodiments could be a significant global market opportunity
Latest:
Pharma 2020: Supplying the FutureRedesigning supply chains could change the shape of bio/pharma
Latest:
OTC and Retail Purchases Round out the View of Patient BehaviorCombining prescription and OTC purchasing patterns gives deeper insights into patient behavior
Latest:
Pharma is under-managing its multi-channel marketing effortsSurvey shows that most digital channels are still experiments with little oversight or follow-through
Latest:
Moving From Big Pharma To A Small Company? You May Be In For A Few SurprisesSponsored by TGaS Advisors
Latest:
Pharma's bread and butter is still made with powderDespite a flurry of specialty pharmaceuticals in innovative formats, traditional powder-based dosages will always be a mainstay
Latest:
Preparing for a serialized supply chainUpcoming California regulatory mandates, and the prospect of a national compliance requirement, are focusing industry attention. Here's what some industry leaders have to say
Latest:
Elevating brand outreach in the age of CovidUsing technology to enable processes, drive cost savings, and deliver better patient outcomes
Latest:
Coordinating payer contracts and direct-to-patient discountingAlthough controversial, patient-focused discounts can play a valuable role in managed-markets programs
Latest:
Simplified approaches to temperature-controlled clinical trial packagingOften, needless cost and complexity--without improving quality and safety--impede cold chain packaging planning
Latest:
Veeva Rolls Out New Features While Transitioning Its CRM platformCompany's annual Commercial Summit updates Veeva Vault CRM status, along with AI partnerships.
Latest:
OPINION: Will Class-Wide REMS Programs Delay New Opioid Approvals?Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers
Latest:
Not just 'social listening' but social understandingHow new social health analytics tools are supercharging pharma's quest for patient insight
